Thanks to our good friends at MassRoots , breaking the news that DEA will keep Cannabis a Schedule 1 substance. Here is the reasoning behind in the Mass Roots Article:
DEA Findings in the Decision
Despite the incredible surge in cannabis acceptance, consumption, and positive results reported by various medical patients from epileptics, to Alzheimer’s patients, to PTSD sufferers to those with chronic pain, the DEA has chosen not to reschedule cannabis, or marijuana as it refers to in the Federal Register report. (It did finally update the spelling of marijuana, losing the “h” that still exists in the original Scheduling document, however.) The DEA’s reasons for delaying rescheduling are: marijuana’s high potential for abuse, the fact that marijuana currently has no accepted medical use in the United States, and that there is a lack of accepted safety for use under medical supervision. Essentially, the DEA still feels that cannabis is addictive, and that there is not enough sound scientific measurement and knowledge about the plant’s psychological, pharmacological, and physiological effects for it to be bought in a grocery store like ibuprofen.
Chuck Rosenberg, DEA Chief, noted that the Food and Drug Administration’s (FDA) findings that cannabis has no “accepted medical use in treatment in the United States” and that it is still a highly abused substance provided part of the basis for his decision, according to NPR. Rosenberg stated that marijuana is not a safe and effective medicine according to the FDA, and therefore would not be rescheduled.
Weigh in America give us your thoughts.